Ceftriaxone sodium, the major product of the company, was certified by Brazil ANVISA
2023-05-25
Ceftriaxone sodium, the major product of the company , was certified by Brazil ANVISA
2023-05-25
The company fluoxetine for the treatment of pigment decolorization disease application project were authorized
2023-05-25
On October 18, 017, the party’s 19th National Congress was successfully held. In this day of celebration, Ruiying Pharmaceutical ushered in its 27th birthday. Here, Ruiying Pharmaceutical has expres
The company participated in the 78th China pharmaceutical fair
2023-05-25
OnNovember28,2017,thecompanyparticipatedinthe78thChinapharmaceuticalfair.Atthisexhibition,thecompanynotonlydisplayedtheoriginalrawmaterialdrugs(cephalosporins,penicillin),intermediateproducts(cephalos
2023-05-25
At about 10:00 am on September 27th, 2017, six members of the Safety Production Second Inspection Team of the Safety Committee of Shandong Province came to Ruiying Pioneer Company to supervise the s
Ruiying Pioneer Intellectual Property Management System Certification Successfully Completed
2023-05-25
At 8:30 a.m. on August 9, 2017, seven members of the expert group of China Knowledge (Beijing) Certification Co., Ltd. visited our company to carry out the certification of the intellectual property
Four kind of sterile bulk drug product are approved by the national GMP certification
2023-05-25
Four kind of sterile bulk drug product are approved by the national GMP certification
Ruiying
